Elizabeth K. Marvin

Elizabeth Marvin practices at Aesthetic Dermatology Associates in Media, Pennsylvania.

Elizabeth Marvin's NPI, 1427581784, was assigned on April 4, 2017. Elizabeth Marvin holds Pennsylvania license MD473836.

Elizabeth Marvin's primary practice is Aesthetic Dermatology Associates, at 176 S New Middletown Rd, Media, PA 19063 in Delaware County. The practice phone is (610) 566-7300.

Elizabeth Marvin's primary practice is Aesthetic Dermatology Associates in Media, Pennsylvania. Elizabeth Marvin is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Elizabeth Marvin to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Elizabeth Marvin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Elizabeth Marvin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Elizabeth Marvin's licenses on file in 2 states: Pennsylvania and Minnesota.

CMS data shows 2,253 Medicare services from Elizabeth Marvin across 16 procedure codes in 2024, for 621 Medicare patients. Medicare paid $113,917 for them. Every service was in an office.

CMS counts 621 Medicare patients who saw Elizabeth Marvin in 2024. The largest group is 65 to 74, with 337 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Elizabeth Marvin's median patient age at 68, with 60% women.

In 2024, Elizabeth Marvin wrote 621 Medicare Part D claims for 296 patients. 93% of them were for generic drugs. CMS names the drug for 504 of them, across 12 drugs with 11 or more claims each, at $63,994 in total drug cost. In 2023, CMS named 518 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Elizabeth Marvin for performance year 2024, reported as part of a group. Elizabeth Marvin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Elizabeth Marvin as offering telehealth. CMS counts 1,200 procedures of removal of skin lesions by Elizabeth Marvin, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Elizabeth Marvin, published from 2018 to 2022. 2022 was the busiest year, with 2. Elizabeth Marvin's most frequent co-authors are Katelyn R. Anderson, MD, David J. Driscoll, MD and Peter Matthew Granger.

CMS Open Payments shows 47 general payments to Elizabeth Marvin from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $186.